Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2833278rdf:typepubmed:Citationlld:pubmed
pubmed-article:2833278lifeskim:mentionsumls-concept:C1135918lld:lifeskim
pubmed-article:2833278lifeskim:mentionsumls-concept:C0034193lld:lifeskim
pubmed-article:2833278lifeskim:mentionsumls-concept:C0034826lld:lifeskim
pubmed-article:2833278lifeskim:mentionsumls-concept:C0205409lld:lifeskim
pubmed-article:2833278pubmed:issue7lld:pubmed
pubmed-article:2833278pubmed:dateCreated1988-5-10lld:pubmed
pubmed-article:2833278pubmed:abstractTextSmooth muscle cells from the gastric antrum of the rabbit were isolated using collagenase and pronase. We examined the characteristics of muscarinic receptors that control contraction of the muscle cell: kinetics, stoichiometry and specificity of both contractile response to muscarinic agents and binding of labeled N-methyl-scopolamine. Cells contracted in the presence of muscarinic agents after a short time (30 sec) while binding of (3H)-NMS reached a plateau after 10 min exposure. Specific binding was saturable and Scatchard analysis revealed a single class of high-affinity binding sites (Kd: 0.5 nM). Oxotremorine was the most potent agonist with an ED50 of 0.6 pM; acetylcholine and carbachol were 10 times less potent. Muscarinic antagonists competed with (3H)-NMS for binding with IC50 values in the same range (nanomolar or less) than those obtained for inhibition of acetylcholine-induced contractions. Pirenzepine antagonized contractile effect of muscarinic agonists with EC50 in a micromolar range. Intracellular levels of cyclic AMP were lowered by muscarinic agonists. Monoclonal anti-muscarinic receptor antibodies M-35 displayed agonist-like activities triggering contraction and lowering cyclic AMP levels of the cells. However, although the antagonist inhibits M-35-induced contractions and cAMP decrease, M-35 had no effect on binding of the antagonist to the muscarinic receptor. These data revealed the presence of an M2-muscarinic receptor subtype involved in the contractile response of the isolated smooth muscle cell.lld:pubmed
pubmed-article:2833278pubmed:languageenglld:pubmed
pubmed-article:2833278pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2833278pubmed:citationSubsetIMlld:pubmed
pubmed-article:2833278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2833278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2833278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2833278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2833278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2833278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2833278pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2833278pubmed:statusMEDLINElld:pubmed
pubmed-article:2833278pubmed:monthAprlld:pubmed
pubmed-article:2833278pubmed:issn0006-2952lld:pubmed
pubmed-article:2833278pubmed:authorpubmed-author:BaldJ GJGlld:pubmed
pubmed-article:2833278pubmed:authorpubmed-author:MagousRRlld:pubmed
pubmed-article:2833278pubmed:authorpubmed-author:StrosbergDDlld:pubmed
pubmed-article:2833278pubmed:authorpubmed-author:MoummiCClld:pubmed
pubmed-article:2833278pubmed:issnTypePrintlld:pubmed
pubmed-article:2833278pubmed:day1lld:pubmed
pubmed-article:2833278pubmed:volume37lld:pubmed
pubmed-article:2833278pubmed:ownerNLMlld:pubmed
pubmed-article:2833278pubmed:authorsCompleteYlld:pubmed
pubmed-article:2833278pubmed:pagination1363-9lld:pubmed
pubmed-article:2833278pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2833278pubmed:meshHeadingpubmed-meshheading:2833278-...lld:pubmed
pubmed-article:2833278pubmed:meshHeadingpubmed-meshheading:2833278-...lld:pubmed
pubmed-article:2833278pubmed:meshHeadingpubmed-meshheading:2833278-...lld:pubmed
pubmed-article:2833278pubmed:meshHeadingpubmed-meshheading:2833278-...lld:pubmed
pubmed-article:2833278pubmed:meshHeadingpubmed-meshheading:2833278-...lld:pubmed
pubmed-article:2833278pubmed:meshHeadingpubmed-meshheading:2833278-...lld:pubmed
pubmed-article:2833278pubmed:meshHeadingpubmed-meshheading:2833278-...lld:pubmed
pubmed-article:2833278pubmed:meshHeadingpubmed-meshheading:2833278-...lld:pubmed
pubmed-article:2833278pubmed:meshHeadingpubmed-meshheading:2833278-...lld:pubmed
pubmed-article:2833278pubmed:meshHeadingpubmed-meshheading:2833278-...lld:pubmed
pubmed-article:2833278pubmed:meshHeadingpubmed-meshheading:2833278-...lld:pubmed
pubmed-article:2833278pubmed:meshHeadingpubmed-meshheading:2833278-...lld:pubmed
pubmed-article:2833278pubmed:meshHeadingpubmed-meshheading:2833278-...lld:pubmed
pubmed-article:2833278pubmed:year1988lld:pubmed
pubmed-article:2833278pubmed:articleTitleMuscarinic receptors in isolated smooth muscle cells from gastric antrum.lld:pubmed
pubmed-article:2833278pubmed:affiliationLaboratoire de Biochimie des Membranes, CNRS ER 228, Faculté de Pharmacie, Montpelier, France.lld:pubmed
pubmed-article:2833278pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2833278pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:2833278pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2833278lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2833278lld:pubmed